YMAB $33.62

0.16 (0.5%)

ymabs.com

YMAB Profile

Market Cap 1 Billion
Y-mAbs Therapeutics Inc is a late-stage clinical biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. Products developed by the company include naxitamab for the treatment of pediatric patients with relapsed or refractory and radiolabeled omburtamab for the treatment of pediatric patients with central nervous system.

YMAB Earnings

EPS -0.70
P/E Ratio --
Previous Wed, Aug 14, 2019
Latest Wed, Nov 13, 2019 (22 days ago) Price +17.76%

YMAB Dividend

--
Ex-Date --
Pay Date --
History --

YMAB Charts

All Time High $34.50 Thu, Dec 5, 2019


Biotech & Pharma Industry Stocks
JNJ 138.87 0.51 -0.37%
MRK 88.40 0.27 -0.30%
PFE 38.00 0.14 -0.37%
AMGN 232.64 1.24 -0.53%
BMY 59.24 0.34 0.58%
NVO 57.16 0.21 -0.37%
ABBV 86.74 0.46 -0.53%
SNY 44.92 0.51 1.15%
LLY 119.09 0.42 0.35%
GILD 65.79 0.96 -1.44%
Symbol Price Day YTD
YMAB $33.62 -0.5% 84.6%


Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com



    TOP    

©2019 Symbol Surfing All Rights Reserved.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Cookies Policy Terms Of Service Privacy Policy